N-Boc-(3S)-3-Phenyl-3-Aminopropionaldehyde Bulk Price 2026: Market Analysis and Procurement Guide
- 2026 Price Forecast: Bulk procurement costs are stabilizing due to optimized synthesis routes, offering significant savings over laboratory-grade pricing.
- Technical Specifications: High industrial purity (≥98.0%) required for CCR5 modulator synthesis, with strict storage protocols at +4°C.
- Supply Chain Security: Partnering with a verified global manufacturer ensures consistent COA documentation and scalable production capacity.
The pharmaceutical landscape for antiretroviral intermediates continues to evolve, with specific demand surging for chiral building blocks used in CCR5 chemokine receptor modulators. Among these, N-Boc-(3S)-3-phenyl-3-aminopropionaldehyde (CAS 135865-78-0) stands out as a critical precursor. For procurement officers and process chemists planning for the 2026 fiscal year, understanding the volatility of bulk pricing versus small-scale laboratory costs is essential. This analysis provides a technical deep dive into the commercial viability, synthesis considerations, and supply chain factors influencing the wholesale cost of this high-value intermediate.
Current Market Pricing Trends for Bulk Orders
Historical market data indicates a significant disparity between research-scale pricing and industrial bulk rates. While small-quantity listings often reflect prices upwards of $300 per gram due to packaging and handling overheads, large-scale procurement operates on a fundamentally different economic model. The bulk price for 2026 is projected to decrease marginally in real terms as manufacturing efficiencies improve, provided that raw material costs for chiral precursors remain stable.
Procurement strategies should focus on volume tiers. Orders exceeding 100 kilograms typically unlock substantial discounts compared to kilogram-scale purchases. However, buyers must remain vigilant regarding quality thresholds. Lower-priced offerings often compromise on enantiomeric excess or contain elevated levels of oxidation byproducts, which can derail downstream synthesis of spirotropane compounds. Therefore, the cost per unit of industrial purity is a more accurate metric than simple weight-based pricing. Sourcing from a reputable global manufacturer ensures that the cost structure includes necessary quality control measures, such as chiral HPLC verification and residual solvent analysis.
Technical Specifications and Stability Profiles
From a process chemistry perspective, the stability of this aldehyde derivative is paramount. The compound, also known synonymously as tert-butyl [(S)-2-formyl-1-phenylethyl]carbamate, possesses a reactive formyl group susceptible to oxidation into the corresponding carboxylic acid. To maintain specification integrity during transport and storage, strict temperature controls are required. The recommended storage temperature is +4°C, and shipping should be conducted under conditions that prevent thermal degradation.
The following table outlines the critical physicochemical properties required for GMP-grade acceptance:
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 135865-78-0 | N/A |
| Molecular Formula | C14 H19 N O3 | N/A |
| Molecular Weight | 249.31 g/mol | MS |
| Assay (Purity) | ≥ 98.0% | HPLC |
| Enantiomeric Excess | ≥ 99.0% | Chiral HPLC |
| Storage Condition | +4°C, Protected from Light | N/A |
| Appearance | White to Off-White Solid | Visual |
When evaluating suppliers, request a comprehensive COA (Certificate of Analysis) that specifically details the impurity profile. Common impurities include the Boc-deprotected amine and the over-oxidized acid. These must be controlled to low ppm levels to prevent interference in subsequent coupling reactions.
Synthesis Route and Manufacturing Capabilities
The commercial viability of this intermediate relies heavily on the efficiency of the synthesis route. Modern manufacturing processes utilize asymmetric reduction or enzymatic resolution to establish the (S)-stereocenter with high fidelity. Scalability is often limited by the cost of chiral catalysts or resolving agents. Consequently, manufacturers who have optimized these steps can offer more competitive pricing without sacrificing optical purity.
For organizations securing supply chains for Maraviroc synthesis or related CCR5 antagonists, consistency is key. Batch-to-batch variability in optical rotation can necessitate re-validation of downstream processes. NINGBO INNO PHARMCHEM CO.,LTD. has established robust production lines capable of delivering multi-ton quantities while maintaining strict stereochemical control. This level of capacity is crucial for pharmaceutical companies aiming to mitigate supply risk in their active pharmaceutical ingredient (API) production.
How to Request Custom Quotes from GMP Manufacturers
Obtaining accurate pricing for 2026 requires direct engagement with production facilities rather than relying on catalog listings. Catalog prices rarely reflect the true cost of bulk chemical manufacturing. When initiating a request for quotation (RFQ), specify the intended application, required annual volume, and packaging preferences (e.g., fiber drums with polyethylene liners versus steel drums).
It is also advisable to discuss lead times and inventory availability. Given the specialized nature of N-Boc-(3S)-3-Phenyl-3-aminopropionaldehyde, made-to-order production may be necessary for very large volumes. Early engagement allows the manufacturer to allocate raw materials and reactor time, securing the quoted price against market fluctuations. Furthermore, verifying the manufacturer's audit status and regulatory compliance history is a standard due diligence step for any critical path intermediate.
Conclusion: Strategic Procurement for 2026
The market for chiral aldehyde intermediates is maturing, with a clear shift towards consolidated supply chains that prioritize quality assurance over lowest-initial-cost. For N-Boc-(3S)-3-phenyl-3-aminopropionaldehyde, the 2026 outlook suggests stable availability for partners who establish long-term contracts. By focusing on industrial purity standards and verifying synthesis capabilities, procurement teams can secure favorable pricing while ensuring the integrity of their final pharmaceutical products. Partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. provides the technical support and volume flexibility required for successful commercialization.